Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial
Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo s...
Saved in:
| Published in | Foods Vol. 12; no. 3; p. 659 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
03.02.2023
MDPI |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3+, CD4+, CD8+ T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. |
|---|---|
| AbstractList | Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3⁺, CD4⁺, CD8⁺ T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3 + , CD4 + , CD8 + T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3+, CD4+, CD8+ T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3+, CD4+, CD8+ T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections.Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from Ganoderma lucidum (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3+, CD4+, CD8+ T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that β-glucan derived from (commonly known as Reishi) holds particular promise in this regard, both in laboratory and in vivo settings. To further investigate the efficacy and safety of Reishi β-glucan in human subjects, a randomized, double-blinded, placebo-controlled clinical trial was conducted among healthy adult volunteers aged 18 to 55. Participants were instructed to self-administer the interventions or placebos on a daily basis for 84 days, with bloodwork assessments conducted at the beginning and end of the study. The results of the trial showed that subjects in the intervention group, who received Reishi β-glucan, exhibited a significant enhancement in various immune cell populations, including CD3 , CD4 , CD8 T-lymphocytes, as well as an improvement in the CD4/CD8 ratio and natural killer cell counts when compared to the placebo group. Additionally, a statistically significant difference was observed in serum immunoglobulin A levels and natural killer cell cytotoxicity between the intervention and placebo groups. Notably, the intervention was found to be safe and well tolerated, with no statistically significant changes observed in markers of kidney or liver function in either group. Overall, the study provides evidence for the ability of Reishi β-glucan to modulate immune responses in healthy adults, thereby potentially bolstering their defense against opportunistic infections. |
| Author | Yang, Min-Feng Chen, Sherwin Chen, Shiu-Nan Chang, Ya-Chih Liu, Ming-Wei Nan, Fan-Hua |
| AuthorAffiliation | 3 Taipei Hospital, Ministry of Health and Welfare, New Taipei City 242062, Taiwan 1 College of Life Science, National Taiwan University, Taipei 10617, Taiwan 2 College of Life Science, National Taiwan Ocean University, Keelung 202301, Taiwan |
| AuthorAffiliation_xml | – name: 3 Taipei Hospital, Ministry of Health and Welfare, New Taipei City 242062, Taiwan – name: 1 College of Life Science, National Taiwan University, Taipei 10617, Taiwan – name: 2 College of Life Science, National Taiwan Ocean University, Keelung 202301, Taiwan |
| Author_xml | – sequence: 1 givenname: Shiu-Nan surname: Chen fullname: Chen, Shiu-Nan – sequence: 2 givenname: Fan-Hua surname: Nan fullname: Nan, Fan-Hua – sequence: 3 givenname: Ming-Wei surname: Liu fullname: Liu, Ming-Wei – sequence: 4 givenname: Min-Feng surname: Yang fullname: Yang, Min-Feng – sequence: 5 givenname: Ya-Chih surname: Chang fullname: Chang, Ya-Chih – sequence: 6 givenname: Sherwin orcidid: 0000-0001-8117-0738 surname: Chen fullname: Chen, Sherwin |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36766186$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkt9qFDEUxgep2Fp76a0EvPFiR_N_EgShtHW7UBGkehsySabNkklqZmZhfQtfxQfxmcx2W-kWwdzkcM53fpxz-J5XezFFV1UvEXxLiITvupTsgDAkkDP5pDrABNJaICb2HsT71dEwLGF5EhFB8LNqn_CGcyT4QfXzbKXDpEefIkgdWPT9FB34lOwUtsl2DX7_qtGMvAdoxsFpPQ-T0RGcuuxXzoIupx7MdUzW5V6DUvR26oGP4NzpMF6vwXFhjeBbClMcncvDDByDLzra1PsfBXCS4phTCCW8zF6HF9XTTofBHd39h9XXj2eXJ-f1xef54uT4ojYM0bE2hLeMWu1ao5tWYASbVkokmUZSNJhbQzDukKGutdoyyttGINJZ3LVNS5wjh9Viy7VJL9VN9r3Oa5W0V7eJlK-UzqM3wSkpObMdkbTBkEIttaTUcAmZ1LbDFBfWhy3rZmp7Z40rK-mwA92tRH-trtKqkBGFBBXAmztATt8nN4yq94NxIejo0jQoLISAkAjc_F_aNIzjRghWpK8fSZdpyrFcdaOigjFJNsBXD4f_O_W9SYqAbAUmp2HIrlPGj7fuKLv4oBBUGzeqHTeWrvpR1z343_o_5srhXA |
| CitedBy_id | crossref_primary_10_1016_j_imr_2024_101089 crossref_primary_10_1039_D4GC02741H crossref_primary_10_1016_j_jafr_2025_101791 crossref_primary_10_1016_j_ijbiomac_2024_131799 crossref_primary_10_1080_0028825X_2024_2375996 crossref_primary_10_1016_j_biopha_2024_116222 crossref_primary_10_1016_j_ijbiomac_2024_131644 crossref_primary_10_1089_ict_2024_56835_luc crossref_primary_10_3390_nu16142298 crossref_primary_10_1016_j_fbio_2024_104277 crossref_primary_10_1177_15347354241280273 crossref_primary_10_3390_ijms252011020 |
| Cites_doi | 10.1016/j.nut.2011.11.012 10.1080/21645515.2021.1880210 10.1016/j.ijbiomac.2014.06.007 10.1615/IntJMedMushrooms.2018026986 10.1186/1756-8722-2-25 10.1080/19390211.2018.1495676 10.1074/jbc.M007386200 10.1158/0008-5472.CAN-14-2467 10.1016/j.ijbiomac.2006.08.009 10.1155/2014/567427 10.1177/1753425915595874 10.1111/j.1365-2249.2005.02962.x 10.1084/jem.20021890 10.1016/S1471-4906(01)01873-7 10.1093/cid/cit816 10.1073/pnas.0400525101 10.7774/cevr.2015.4.1.54 10.3109/19390211.2013.820248 10.1615/CritRevImmunol.v27.i2.10 10.1006/fsim.2001.0345 10.4049/jimmunol.171.4.1630 10.1126/science.1250684 10.1152/physiolgenomics.00128.2004 10.4103/0976-0105.177703 10.2174/1871520615666150518092547 10.1016/j.nut.2017.03.003 10.1002/jsfa.4409 10.1007/s00262-016-1792-y 10.3390/ijms22115760 10.1586/14760584.2014.920236 10.1089/jmf.2005.8.159 10.1016/j.fct.2011.08.007 10.1016/j.nano.2016.08.022 10.1093/intimm/dxm061 10.1016/j.ctim.2018.12.004 10.1007/s10875-015-0201-1 10.1124/pr.109.001073 10.1080/07315724.2012.10720441 10.1124/mol.106.022327 10.1615/IntJMedMushr.v12.i1.10 10.1016/j.jaci.2009.08.040 10.1016/j.chom.2011.04.006 10.1007/s00204-016-1744-5 10.4161/cbt.8.3.7337 10.4049/jimmunol.163.6.3045 10.1016/j.carbpol.2013.01.026 10.2217/fvl.14.70 10.1007/s10856-013-4895-4 10.1517/14712598.5.5.691 10.1016/j.intimp.2006.08.011 10.1038/s41467-018-03014-4 10.1084/jem.192.4.595 10.1016/j.cell.2004.05.001 10.1016/0192-0561(87)90049-X 10.3390/jcdd9120423 |
| ContentType | Journal Article |
| Copyright | 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 by the authors. 2023 |
| Copyright_xml | – notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 by the authors. 2023 |
| DBID | AAYXX CITATION NPM 3V. 7QR 7T7 7X2 8FD 8FE 8FH 8FK ABUWG AFKRA ATCPS AZQEC BENPR BHPHI C1K CCPQU COVID DWQXO FR3 HCIFZ M0K P64 PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI 7X8 7S9 L.6 5PM DOA |
| DOI | 10.3390/foods12030659 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Agricultural Science Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Agricultural & Environmental Science Collection ProQuest Central Essentials ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College Coronavirus Research Database ProQuest Central Korea Engineering Research Database SciTech Premium Collection Agricultural Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Agricultural Science Database Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central Natural Science Collection ProQuest Central Korea Agricultural & Environmental Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest One Academic Eastern Edition Agricultural Science Collection Coronavirus Research Database ProQuest SciTech Collection Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA Agricultural Science Database MEDLINE - Academic CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Diet & Clinical Nutrition |
| EISSN | 2304-8158 |
| ExternalDocumentID | oai_doaj_org_article_9965df39472040a9a944c69059adf242 PMC9914031 36766186 10_3390_foods12030659 |
| Genre | Journal Article |
| GeographicLocations | United States--US Taiwan |
| GeographicLocations_xml | – name: Taiwan – name: United States--US |
| GrantInformation_xml | – fundername: SBG Biomedical Research (Los Angeles, CA, USA) grantid: HS02103526 |
| GroupedDBID | 53G 5VS 7X2 8FE 8FH AADQD AAFWJ AAHBH AAYXX ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS ATCPS BCNDV BENPR BHPHI CCPQU CITATION GROUPED_DOAJ HCIFZ HYE IAO ITC KQ8 M0K M48 MODMG M~E OK1 OZF PHGZM PHGZT PIMPY PROAC RPM NPM 3V. 7QR 7T7 8FD 8FK ABUWG AZQEC C1K COVID DWQXO FR3 P64 PKEHL PQEST PQQKQ PQUKI 7X8 7S9 L.6 5PM PUEGO |
| ID | FETCH-LOGICAL-c514t-c36b54daebca7b82107b99195a198726dc322f1c4ebdad546b7813fd2fb7b3ee3 |
| IEDL.DBID | M48 |
| ISSN | 2304-8158 |
| IngestDate | Wed Aug 27 01:18:45 EDT 2025 Thu Aug 21 18:38:36 EDT 2025 Fri Jul 11 08:22:40 EDT 2025 Thu Jul 10 22:09:46 EDT 2025 Mon Jun 30 11:11:42 EDT 2025 Mon Jul 21 05:58:45 EDT 2025 Tue Jul 01 02:57:55 EDT 2025 Thu Apr 24 22:53:09 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Creatinine Reishi β-glucan innate and adaptive immune response Ganoderma lucidum T-lymphocytes immune modulation randomized control trials |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c514t-c36b54daebca7b82107b99195a198726dc322f1c4ebdad546b7813fd2fb7b3ee3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8117-0738 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/foods12030659 |
| PMID | 36766186 |
| PQID | 2774855937 |
| PQPubID | 2032399 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_9965df39472040a9a944c69059adf242 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9914031 proquest_miscellaneous_2888003827 proquest_miscellaneous_2775627885 proquest_journals_2774855937 pubmed_primary_36766186 crossref_citationtrail_10_3390_foods12030659 crossref_primary_10_3390_foods12030659 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20230203 |
| PublicationDateYYYYMMDD | 2023-02-03 |
| PublicationDate_xml | – month: 2 year: 2023 text: 20230203 day: 3 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Foods |
| PublicationTitleAlternate | Foods |
| PublicationYear | 2023 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Cobb (ref_53) 2004; 117 Zhang (ref_13) 2015; 15 Vecchione (ref_15) 2017; 13 Gao (ref_32) 2005; 8 Hawkins (ref_17) 2019; 42 Sahoo (ref_54) 2001; 11 Lin (ref_20) 2006; 70 Talbott (ref_43) 2012; 31 Vos (ref_22) 2007; 27 Ruthes (ref_39) 2013; 94 ref_16 Kim (ref_34) 2011; 91 Ikewaki (ref_27) 2021; 17 Cheng (ref_28) 2014; 345 Yan (ref_36) 2005; 5 McFarlin (ref_56) 2013; 10 Sabroe (ref_12) 2003; 171 Lehne (ref_33) 2006; 143 Damen (ref_57) 2001; 22 Bryant (ref_11) 2009; 61 Rubin (ref_3) 2014; 58 Noss (ref_52) 2015; 21 Chinen (ref_2) 2010; 125 ref_21 Demir (ref_49) 2007; 7 Fuller (ref_42) 2012; 28 Fitzgerald (ref_8) 2004; 19 Netea (ref_30) 2011; 9 Geng (ref_5) 2015; 75 Wu (ref_40) 2014; 2014 Wasser (ref_47) 1999; 19 Tabeta (ref_9) 2004; 101 ref_31 Rhee (ref_7) 2000; 275 Chan (ref_51) 2007; 19 Mah (ref_44) 2020; 17 Yan (ref_25) 1999; 163 Patel (ref_14) 2014; 9 Driscoll (ref_35) 2009; 8 Henao (ref_48) 2018; 20 Vetvicka (ref_24) 2007; 40 Sherwood (ref_26) 1987; 9 Li (ref_58) 2018; 9 Chen (ref_37) 2011; 49 Brown (ref_23) 2003; 197 Nair (ref_41) 2016; 7 Gupta (ref_10) 2014; 13 ref_45 Fuller (ref_55) 2017; 39–40 Wasser (ref_19) 2010; 12 Rosso (ref_60) 2013; 24 Becker (ref_59) 2016; 65 Vabulas (ref_6) 2000; 192 Chan (ref_50) 2009; 2 Lim (ref_4) 2015; 4 Wu (ref_18) 2016; 90 Picard (ref_1) 2015; 35 Boraschi (ref_29) 2015; 2015 Komura (ref_38) 2014; 70 Lin (ref_46) 2004; 25 |
| References_xml | – volume: 28 start-page: 665 year: 2012 ident: ref_42 article-title: Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections publication-title: Nutrition doi: 10.1016/j.nut.2011.11.012 – volume: 17 start-page: 2808 year: 2021 ident: ref_27 article-title: β-glucan: Wide-spectrum immune-balancing food-supplement-based enteric (β-WIFE) vaccine adjuvant approach to COVID-19 publication-title: Hum. Vaccin. Immunother. doi: 10.1080/21645515.2021.1880210 – volume: 70 start-page: 354 year: 2014 ident: ref_38 article-title: Water-soluble polysaccharides from Pleurotus ostreatus var. florida mycelial biomass publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2014.06.007 – volume: 20 start-page: 705 year: 2018 ident: ref_48 article-title: Randomized Clinical Trial for the Evaluation of Immune Modulation by Yogurt Enriched with β-glucan from Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), in Children from Medellin, Colombia publication-title: Int. J. Med. Mushrooms doi: 10.1615/IntJMedMushrooms.2018026986 – volume: 2 start-page: 25 year: 2009 ident: ref_50 article-title: The effects of beta-glucan on human immune and cancer cells publication-title: J. Hematol. Oncol. doi: 10.1186/1756-8722-2-25 – volume: 17 start-page: 200 year: 2020 ident: ref_44 article-title: Beverage Containing Dispersible Yeast β-Glucan Decreases Cold/Flu Symptomatic Days after Intense Exercise: A Randomized Controlled Trial publication-title: J. Diet. Suppl. doi: 10.1080/19390211.2018.1495676 – volume: 275 start-page: 34035 year: 2000 ident: ref_7 article-title: Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase publication-title: J. Biol. Chem. doi: 10.1074/jbc.M007386200 – volume: 75 start-page: 1959 year: 2015 ident: ref_5 article-title: TLR5 Ligand-Secreting T Cells Reshape the Tumor Microenvironment and Enhance Antitumor Activity publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-2467 – ident: ref_31 – volume: 40 start-page: 291 year: 2007 ident: ref_24 article-title: Orally administered marine (1-->3)-beta-D-glucan Phycarine stimulates both humoral and cellular immunity publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2006.08.009 – volume: 2014 start-page: 567427 year: 2014 ident: ref_40 article-title: Oral Administration of MBG to Modulate Immune Responses and Suppress OVA-Sensitized Allergy in a Murine Model publication-title: Evid. Based. Complement. Alternat. Med. doi: 10.1155/2014/567427 – volume: 21 start-page: 759 year: 2015 ident: ref_52 article-title: Cellular and molecular mechanisms of fungal β-(1→6)-glucan in macrophages publication-title: Innate. Immun. doi: 10.1177/1753425915595874 – volume: 143 start-page: 65 year: 2006 ident: ref_33 article-title: Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2005.02962.x – volume: 197 start-page: 1119 year: 2003 ident: ref_23 article-title: Dectin-1 mediates the biological effects of beta-glucans publication-title: J. Exp. Med. doi: 10.1084/jem.20021890 – volume: 22 start-page: 205 year: 2001 ident: ref_57 article-title: IgA and the IgA Fc receptor publication-title: Trends Immunol. doi: 10.1016/S1471-4906(01)01873-7 – volume: 58 start-page: 309 year: 2014 ident: ref_3 article-title: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host publication-title: Clin. Infect. Dis. doi: 10.1093/cid/cit816 – ident: ref_45 – volume: 101 start-page: 3516 year: 2004 ident: ref_9 article-title: Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0400525101 – volume: 4 start-page: 54 year: 2015 ident: ref_4 article-title: Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease publication-title: Clin. Exp. Vaccine Res. doi: 10.7774/cevr.2015.4.1.54 – volume: 10 start-page: 171 year: 2013 ident: ref_56 article-title: Baker’s yeast beta glucan supplementation increases salivary IgA and decreases cold/flu symptomatic days after intense exercise publication-title: J. Diet. Suppl. doi: 10.3109/19390211.2013.820248 – volume: 27 start-page: 97 year: 2007 ident: ref_22 article-title: Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates publication-title: Crit. Rev. Immunol. doi: 10.1615/CritRevImmunol.v27.i2.10 – volume: 11 start-page: 683 year: 2001 ident: ref_54 article-title: Effect of dietary beta-1,3 glucan on immune responses and disease resistance of healthy and aflatoxin B1-induced immunocompromised rohu (Labeo rohita Hamilton) publication-title: Fish Shellfish Immunol. doi: 10.1006/fsim.2001.0345 – volume: 171 start-page: 1630 year: 2003 ident: ref_12 article-title: Toll-like receptors in health and disease: Complex questions remain publication-title: J. Immunol. doi: 10.4049/jimmunol.171.4.1630 – volume: 345 start-page: 1250684 year: 2014 ident: ref_28 article-title: mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity publication-title: Science doi: 10.1126/science.1250684 – volume: 19 start-page: 319 year: 2004 ident: ref_8 article-title: The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades publication-title: Physiol. Genom. doi: 10.1152/physiolgenomics.00128.2004 – volume: 7 start-page: 27 year: 2016 ident: ref_41 article-title: A simple practice guide for dose conversion between animals and human publication-title: J. Basic. Clin. Pharm. doi: 10.4103/0976-0105.177703 – volume: 15 start-page: 1134 year: 2015 ident: ref_13 article-title: Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer publication-title: Anticancer Agents Med. Chem. doi: 10.2174/1871520615666150518092547 – volume: 39–40 start-page: 30 year: 2017 ident: ref_55 article-title: Yeast-derived β-1,3/1,6 glucan, upper respiratory tract infection and innate immunity in older adults publication-title: Nutrition doi: 10.1016/j.nut.2017.03.003 – volume: 91 start-page: 1915 year: 2011 ident: ref_34 article-title: (1-3)(1-6)-β-glucan-enriched materials from Lentinus edodes mushroom as a high-fibre and low-calorie flour substitute for baked foods publication-title: J. Sci. Food Agric. doi: 10.1002/jsfa.4409 – volume: 65 start-page: 477 year: 2016 ident: ref_59 article-title: Selection and expansion of natural killer cells for NK cell-based immunotherapy publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-016-1792-y – ident: ref_16 doi: 10.3390/ijms22115760 – volume: 13 start-page: 909 year: 2014 ident: ref_10 article-title: Toll-like receptor-based adjuvants: Enhancing the immune response to vaccines against infectious diseases of chicken publication-title: Expert Rev. Vaccines doi: 10.1586/14760584.2014.920236 – volume: 8 start-page: 159 year: 2005 ident: ref_32 article-title: Effects of water-soluble Ganoderma lucidum polysaccharides on the immune functions of patients with advanced lung cancer publication-title: J. Med. Food doi: 10.1089/jmf.2005.8.159 – volume: 49 start-page: 2890 year: 2011 ident: ref_37 article-title: Safety assessment of mushroom β-glucan: Subchronic toxicity in rodents and mutagenicity studies publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2011.08.007 – volume: 13 start-page: 275 year: 2017 ident: ref_15 article-title: Oil/water nano-emulsion loaded with cobalt ferrite oxide nanocubes for photo-acoustic and magnetic resonance dual imaging in cancer: In vitro and preclinical studies publication-title: Nanomedicine doi: 10.1016/j.nano.2016.08.022 – volume: 2015 start-page: 478408 year: 2015 ident: ref_29 article-title: Innate Immune Memory: The Latest Frontier of Adjuvanticity publication-title: J. Immunol. Res. – volume: 19 start-page: 891 year: 2007 ident: ref_51 article-title: Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley publication-title: Int. Immunol. doi: 10.1093/intimm/dxm061 – volume: 42 start-page: 361 year: 2019 ident: ref_17 article-title: Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials publication-title: Complement. Ther. Med. doi: 10.1016/j.ctim.2018.12.004 – volume: 35 start-page: 696 year: 2015 ident: ref_1 article-title: Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 publication-title: J. Clin. Immunol. doi: 10.1007/s10875-015-0201-1 – volume: 61 start-page: 177 year: 2009 ident: ref_11 article-title: Therapeutic targeting of Toll-like receptors for infectious and inflammatory diseases and cancer publication-title: Pharmacol. Rev. doi: 10.1124/pr.109.001073 – volume: 31 start-page: 295 year: 2012 ident: ref_43 article-title: Baker’s yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women publication-title: J. Am. Coll. Nutr. doi: 10.1080/07315724.2012.10720441 – volume: 70 start-page: 637 year: 2006 ident: ref_20 article-title: Polysaccharide purified from Ganoderma lucidum induces gene expression changes in human dendritic cells and promotes T helper 1 immune response in BALB/c mice publication-title: Mol. Pharmacol. doi: 10.1124/mol.106.022327 – volume: 12 start-page: 1 year: 2010 ident: ref_19 article-title: Medicinal Mushroom Science: History, Current Status, Future Trends, and Unsolved Problems publication-title: Int. J. Med. Mushrooms doi: 10.1615/IntJMedMushr.v12.i1.10 – volume: 125 start-page: S195 year: 2010 ident: ref_2 article-title: Secondary immunodeficiencies, including HIV infection publication-title: J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2009.08.040 – volume: 9 start-page: 355 year: 2011 ident: ref_30 article-title: Trained immunity: A memory for innate host defense publication-title: Cell Host Microbe doi: 10.1016/j.chom.2011.04.006 – volume: 90 start-page: 1817 year: 2016 ident: ref_18 article-title: The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview publication-title: Arch. Toxicol. doi: 10.1007/s00204-016-1744-5 – volume: 8 start-page: 218 year: 2009 ident: ref_35 article-title: Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy publication-title: Cancer Biol. Ther. doi: 10.4161/cbt.8.3.7337 – volume: 163 start-page: 3045 year: 1999 ident: ref_25 article-title: Beta-glucan, a “specific” biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18) publication-title: J. Immunol. doi: 10.4049/jimmunol.163.6.3045 – volume: 94 start-page: 129 year: 2013 ident: ref_39 article-title: Lactarius rufus (1→3),(1→6)-β-D-glucans: Structure, antinociceptive and anti-inflammatory effects publication-title: Carbohydr. Polym. doi: 10.1016/j.carbpol.2013.01.026 – volume: 9 start-page: 811 year: 2014 ident: ref_14 article-title: Novel drugs targeting Toll-like receptors for antiviral therapy publication-title: Future Virol. doi: 10.2217/fvl.14.70 – volume: 24 start-page: 1473 year: 2013 ident: ref_60 article-title: Cross-linked hyaluronic acid sub-micron particles: In vitro and in vivo biodistribution study in cancer xenograft model publication-title: J. Mater. Sci. Mater. Med. doi: 10.1007/s10856-013-4895-4 – volume: 5 start-page: 691 year: 2005 ident: ref_36 article-title: Yeast whole glucan particle (WGP) beta-glucan in conjunction with antitumour monoclonal antibodies to treat cancer publication-title: Expert Opin. Biol. Ther. doi: 10.1517/14712598.5.5.691 – volume: 7 start-page: 113 year: 2007 ident: ref_49 article-title: Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2006.08.011 – volume: 19 start-page: 65 year: 1999 ident: ref_47 article-title: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective publication-title: Crit. Rev. Immunol. – volume: 25 start-page: 1387 year: 2004 ident: ref_46 article-title: Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms publication-title: Acta. Pharmacol. Sin. – volume: 9 start-page: 751 year: 2018 ident: ref_58 article-title: Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida publication-title: Nat. Commun. doi: 10.1038/s41467-018-03014-4 – volume: 192 start-page: 595 year: 2000 ident: ref_6 article-title: Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF) 6 publication-title: J. Exp. Med. doi: 10.1084/jem.192.4.595 – volume: 117 start-page: 677 year: 2004 ident: ref_53 article-title: Polysaccharide processing and presentation by the MHCII pathway publication-title: Cell doi: 10.1016/j.cell.2004.05.001 – volume: 9 start-page: 261 year: 1987 ident: ref_26 article-title: Enhancement of interleukin-1 and interleukin-2 production by soluble glucan publication-title: Int. J. Immunopharmacol. doi: 10.1016/0192-0561(87)90049-X – ident: ref_21 doi: 10.3390/jcdd9120423 |
| SSID | ssj0000913832 |
| Score | 2.3179462 |
| Snippet | Fungi-derived β-glucan, a type of glucopolysaccharide, has been shown to possess immune-modulatory properties in clinical settings. Studies have indicated that... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 659 |
| SubjectTerms | adults Biocompatibility Blood blood serum CD3 antigen CD4 antigen CD8 antigen Chronic fatigue syndrome Clinical trials Cytotoxicity Disease Food science Fungi Ganoderma lucidum Glucan Hematology humans immune modulation Immune response Immune system Immunoglobulin A Immunomodulation In vivo methods and tests Informed consent innate and adaptive immune response Intervention kidneys liver function Lymphocytes Lymphocytes T Mushrooms Natural killer cells NMR Nuclear magnetic resonance Placebos randomized clinical trials Reishi Spectrum analysis Statistical analysis T-lymphocytes Toxicity β-Glucan |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnnpBQHkYChok1FOsZr1ery1OoekDpPaAWtSbtU9hKbERTSq1_6J_pT-E38SM7VgJ4nHhFmVHlp2Z2fnGmf0-xt4R4V2hQhb7IAU2KJhSemyy2Gms9VZIb3M6KHx6lp1cpJ8u5eWa1BfNhHX0wN0Pt494XLogipTUVMa60EWaWmzpZKFdwPpCuy_WvLVmqt2DC46tV9KRagrs6_dD07grnhBEJl7StSLUcvX_DmD-Oie5VniOHrGHPWKESXenj9kDXz9h0bTyC9iDntZzBmcrVv0ddnc4MHhDE-AjnQDxcNq4XqkLzA38uI_5SLwHPspgGh-T9FkNU4zGa--AjpzAsa5JJm2uARcrt5xDVUN3aOkGJsTaAV8wbNEvCCBHMIHPunbNvLrFCxx08-8z_HhOAf6UXRwdnh-cxL3yQmwRQC1iKzIjU6dpUkqZHNtCZRBIFlLTO4okcxb3gcBt6o3TTqaZUTkXwSXBKCO8F8_YVt3U_gUDy50KgVAHSYgHZ4KXwXIjzVgHHcYRG61cUdqelpzUMWYltifkuXLDcxHbG8y_dXwcfzL8QH4djIhGu_0Cg6vsg6v8V3BFbHcVFWWf21dlgog5x0ZMqIi9HZYxK-mvFl37ZtnaILBUeS7_YpPj3onJkeB1nneBNtwt8eiRkkHE1EYIbjzO5kpdfW3ZwdFPmHL85f94_ldsO0FQ106pi122tfi-9K8RhC3MmzbffgKGgDE5 priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LbtNAFB1BumGDeGMo6CKhrmI19nj8EAuUNmkLUiNUtag7a54lUmKXJkEqf8Gv8CF8E_faE9Mg6M7yXFm27mPOjO-cw9hbIrwrMpeG1gmOCxRMKTlQaWgkzvWaC6tzOih8PEmPzpKP5-Lcb7gtfFvluiY2hdrUmvbId2PEKTnCX569v_wakmoU_V31Ehp32RaW4Dzvsa298eTTSbfLQqyXGLMtuSbH9f2uq2uziGKCysRPemMyajj7_wU0_-6XvDEBHTxg9z1yhGHr6ofsjq0esWA0tUvYAU_vOYPJml3_Mfsx7pi8oXbwgU6CWDiujVfsAnUNv36GUZ-_g6ifwig8JAm0CkYYld-sATp6AoeyIrm0uQQcnJrVHKYVtIeXrmFI7B3wGcMX_YNAsg9DOJGVqefT7_iA_bYPfoaXpxToT9jZwfh0_yj0CgyhRiC1DDVPlUiMpI6pTOW4PMwUAspCSNqriFOjsR64SCdWGWlEkqosj7gzsVOZ4tbyp6xX1ZV9zkBHJnOO0AdJiTujnBVOR0qogXTSDQLWX7ui1J6enFQyZiUuU8hz5YbnArbTmV-2vBz_M9wjv3ZGRKfd3KivLkqfnSUu-oRxvEhIsmcgC1kkiU4LhJ7SOAQxAdteR0Xpc3xR_onIgL3phjE76ZeLrGy9amwQYGZ5Lm6xybGGYpLE-JxnbaB1b0t8eqRoELBsIwQ3PmdzpJp-aVjC0U-YetGL21_9JbsXI2xr-tD5Nustr1b2FcKspXrtc-k3zg4rgw priority: 102 providerName: ProQuest |
| Title | Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36766186 https://www.proquest.com/docview/2774855937 https://www.proquest.com/docview/2775627885 https://www.proquest.com/docview/2888003827 https://pubmed.ncbi.nlm.nih.gov/PMC9914031 https://doaj.org/article/9965df39472040a9a944c69059adf242 |
| Volume | 12 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3bbtNAEF1B-8IL4o6hRIOE-hRD7PX6IoRQ2qQtSIlQ1aC-WbveXbCU2JAmiPAX_AofwjcxYzsGQ-lblJ1YTmZm9xxn9xzGnpHgXRLZ0DVWcCQo2FJyoEJXS1zrMy5MFtNB4ck0PJkFb8_F-W9JoeYHvLiU2pGf1Gw5f_718-Y1NvwrYpxI2V_YstQXnk_oVyTX2S4uShGZGUwapF9NyomHXMyvVTb__VRnVarE-y9DnH9vnPxjJTq6xW42EBKGdc5vs2umuMOcUW5WsA-NzuccpluZ_bvs-7iV9IbSwhs6EmJgUurGugvUBn7-cL0-fwleP4SRe0xeaAWMsDy_GA10BgWOZUG-aQsJOJjr9QLyAupTTBsYkowHvMc6xkQhouzDEE5loctF_g0vcFhviJ_jyzOq-HtsdjQ-OzxxGysGN0NEtXIzHioRaElbpyIVI0-MFCLLREh6aOGHOsOJwXpZYJSWWgShimKPW-1bFSluDL_PdoqyMA8ZZJ6OrCUYQp7iVitrhM08JdRAWmkHDutvU5FmjU452WXMU-QrlLm0kzmH7bfhn2qBjv8FHlBe2yDS1a7eKJcf0qZNU2R_QlueBOTdM5CJTIIgCxPEoFJbRDMO29tWRbqt1dRHCB0jM-ORw562w9im9N-LLEy5rmIQaUZxLK6IiXEyxW7x8ToP6kJr75aE9cjawGFRpwQ7X6c7UuQfK7lwzBP2oPfo6lt_zG74iN-qDel8j-2slmvzBPHWSvXY7sF4-u60Vz2v6FV99QtwTy-w |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VdAEbxBtDgUGCrmLV9vgphFDapE1oE6EqRd2ZeUKkxC5NAgp_wY-w4EP4Ju71iwZBd91ZnquRrfuYc-2Zcwh5gYR3SWRCW5uAQYMCKcUdEdqKw1ovWaBljAeFh6Owf-K_PQ1ON8iP-iwMbqusa2JRqFUu8Rv5jgc4JQb4y6I3Z59tVI3Cv6u1hEYZFod69RVatvnrQRf8-9Lz9nvjvb5dqQrYEsDBwpYsFIGvOO4CikQMLU8kACQlAcf-2wuVhBg3rvS1UFwFfiii2GVGeUZEgmnNYN5rZNNnoeO1yOZub_TuuPmqgyybkCMlmSdjibNj8lzNXQ-hOfKhXlj8Co2AfwHbv_dnXljw9m-RmxVSpZ0ytG6TDZ3dIVZ3ohd0m1Z0olM6qtn875LvvYY5nOaGDvDkiabDXFUKYVSs6K-ftttmr6jbDmnXPkDJtYx2IQu-aEXxqAs94BnKs804hcGJWs7oJKPlYakV7SBbCH0P6QLxAMC1TTv0mGcqn02-wQR75b77KVyOMbHukZMr8c190sryTD8kVLoqMgbRDkqXGyWMDox0RSAcbrhxLNKuXZHKig4dVTmmKbRF6Ll0zXMW2W7Mz0oekP8Z7qJfGyOk7y5u5Ocf06oapNBkBsqwxEeJIIcnPPF9GSYAdbkyAJosslVHRVrVlHn6JwMs8rwZhmqAv3h4pvNlYQOANorj4BKbGGo2JKUH8zwoA615WuTvQwUFi0RrIbj2Ousj2eRTwUoOfoJUdx9d_ujPyPX-eHiUHg1Gh4_JDQ8gY7EHnm2R1uJ8qZ8AxFuIp1VeUfLhqlP5N634aZo |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3LbtNAFB2VVEJsEG8MBS4SdBUrscdPIYTSJmlDaVRVLerOzHhmIFJilyYBlb_gV1jyEXwT9_pFg6C77izPaGTrPuZc-845jL0gwrs4NIGtjc-xQMGQEl0Z2ErgXp9yX6cRHRTeHwe7x97bE_9kjf2sz8JQW2WdE4tErfKUvpF3XMQpEcJfHnZM1RZx0B--Of1sk4IU_Wmt5TRKF9nT51-xfJu_HvXR1i9ddzg42t61K4UBO0WgsLBTHkjfU4I6gkIZYfkTSgRMsS-oFncDlaK_Gyf1tFRC-V4gw8jhRrlGhpJrzXHda2w9pKqoxda3BuODw-YLDzFuYryUxJ6cx92OyXM1d1yC6cSNemEjLPQC_gVy_-7VvLD5DW-xmxVqhV7pZrfZms7uMKs_0QvYhIpadArjmtn_Lvs-aFjEITcwolMoGvZzVamFgTyHXz9sp81fgdMOoG_vkPxaBn2MiC9aAR17gR2RkVTbTAAOTtRyBpMMyoNT59Aj5hB4j6GDvoEgtg09OBSZymeTb7jAdtmDP8XLIwqye-z4Smxzn7WyPNMPGaSOCo0h5EMy5kZJo32TOtKXXWGE6VqsXZsiSStqdFLomCZYIpHlkhXLWWyzmX5acoL8b-IW2bWZRFTexY387GNSZYYEC05fGR57JBfUFbGIPS8NYoS9QhkEUBbbqL0iqfLLPPkTDRZ73gxjZqDfPSLT-bKYg-A2jCL_kjkR5m8MUBfXeVA6WvO0xOVHagoWC1dccOV1VkeyyaeCoRzthGHvPLr80Z-x6xjCybvReO8xu-Eieiza4fkGay3OlvoJor2FfFqFFbAPVx3JvwFFO23P |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+Immune+Modulation+by+%CE%B2-1%2C3%3B+1%2C6+D-Glucan+Derived+from+Ganoderma+lucidum+in+Healthy+Adult+Volunteers%2C+A+Randomized+Controlled+Trial&rft.jtitle=Foods&rft.au=Chen%2C+Shiu-Nan&rft.au=Fan-Hua%2C+Nan&rft.au=Ming-Wei%2C+Liu&rft.au=Min-Feng%2C+Yang&rft.date=2023-02-03&rft.pub=MDPI+AG&rft.eissn=2304-8158&rft.volume=12&rft.issue=3&rft.spage=659&rft_id=info:doi/10.3390%2Ffoods12030659&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2304-8158&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2304-8158&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2304-8158&client=summon |